NO20091081L - Oganiske forbindelser - Google Patents

Oganiske forbindelser

Info

Publication number
NO20091081L
NO20091081L NO20091081A NO20091081A NO20091081L NO 20091081 L NO20091081 L NO 20091081L NO 20091081 A NO20091081 A NO 20091081A NO 20091081 A NO20091081 A NO 20091081A NO 20091081 L NO20091081 L NO 20091081L
Authority
NO
Norway
Prior art keywords
organic compounds
epothilone
crystal forms
new crystal
compounds
Prior art date
Application number
NO20091081A
Other languages
English (en)
Norwegian (no)
Inventor
Ernst Kuesters
Michael Mutz
Frank Stowasser
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=37685905&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20091081(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of NO20091081L publication Critical patent/NO20091081L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO20091081A 2006-08-16 2009-03-11 Oganiske forbindelser NO20091081L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP06119043 2006-08-16
PCT/EP2007/007173 WO2008019820A2 (fr) 2006-08-16 2007-08-14 Composés organiques

Publications (1)

Publication Number Publication Date
NO20091081L true NO20091081L (no) 2009-03-16

Family

ID=37685905

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20091081A NO20091081L (no) 2006-08-16 2009-03-11 Oganiske forbindelser

Country Status (22)

Country Link
US (1) US8178566B2 (fr)
EP (1) EP2064216A2 (fr)
JP (1) JP2010500387A (fr)
KR (1) KR20090038902A (fr)
CN (1) CN101506217B (fr)
AR (1) AR062375A1 (fr)
AU (1) AU2007286454A1 (fr)
BR (1) BRPI0715963A2 (fr)
CA (1) CA2658475A1 (fr)
CL (1) CL2007002362A1 (fr)
IL (1) IL196558A0 (fr)
MA (1) MA30656B1 (fr)
MX (1) MX2009001635A (fr)
MY (1) MY148355A (fr)
NO (1) NO20091081L (fr)
NZ (1) NZ574194A (fr)
PE (1) PE20081317A1 (fr)
RU (1) RU2009109352A (fr)
TN (1) TN2009000044A1 (fr)
TW (1) TW200815455A (fr)
WO (1) WO2008019820A2 (fr)
ZA (1) ZA200900227B (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2927832C (fr) 2010-05-18 2021-03-23 Cerulean Pharma Inc. Conjugues d'agent therapeutique polymere renfermant de la cyclodextrine et leur utilisation
CN103910742B (zh) * 2013-01-07 2016-07-13 浙江海正药业股份有限公司 一种制备埃博霉素b无定形粉末的方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20080016756A (ko) 1998-02-05 2008-02-21 노파르티스 아게 유기화합물 함유 조성물
US6194181B1 (en) * 1998-02-19 2001-02-27 Novartis Ag Fermentative preparation process for and crystal forms of cytostatics
UA75365C2 (en) 2000-08-16 2006-04-17 Bristol Myers Squibb Co Epothilone analog polymorph modifications, a method for obtaining thereof (variants), a pharmaceutical composition based thereon
GB0029895D0 (en) 2000-12-07 2001-01-24 Novartis Ag Organic compounds
HRP20050278A2 (en) * 2002-09-23 2005-10-31 Bristol-Myers Squibb Company Methods for the preparation, isolation and purification of epothilone b, and x-ray crystal structures of epothilone b

Also Published As

Publication number Publication date
KR20090038902A (ko) 2009-04-21
TW200815455A (en) 2008-04-01
CL2007002362A1 (es) 2008-08-08
WO2008019820A3 (fr) 2008-04-17
JP2010500387A (ja) 2010-01-07
US8178566B2 (en) 2012-05-15
NZ574194A (en) 2011-12-22
CN101506217B (zh) 2012-09-05
CN101506217A (zh) 2009-08-12
MY148355A (en) 2013-03-29
MX2009001635A (es) 2009-02-23
TN2009000044A1 (en) 2010-08-19
IL196558A0 (en) 2009-11-18
AR062375A1 (es) 2008-11-05
ZA200900227B (en) 2009-12-30
WO2008019820A2 (fr) 2008-02-21
MA30656B1 (fr) 2009-08-03
AU2007286454A1 (en) 2008-02-21
US20100160393A1 (en) 2010-06-24
RU2009109352A (ru) 2010-09-27
PE20081317A1 (es) 2008-10-28
BRPI0715963A2 (pt) 2013-08-06
CA2658475A1 (fr) 2008-02-21
EP2064216A2 (fr) 2009-06-03

Similar Documents

Publication Publication Date Title
CY2020025I2 (el) Αναστολεις βητα-λακταμασων
DK2086960T3 (da) Nye inhibitorer af glutaminylcyclase.
MA32938B1 (fr) Composes organiques
UY30639A1 (es) Derivados sustituidos de 2h-ftalazin-1-ona, sus formas cristalinas, proceso de preparacion y aplicaciones
BRPI0718509A2 (pt) compostos orgânicos heterocíclicos
MA32939B1 (fr) Composes organiques
DK2074123T3 (da) Nye anxiolytiske forbindelser
FI20070063A0 (fi) Orgaaninen kenttävaikutustransistori
BRPI0718874A2 (pt) Compostos orgânicos
NO20084803L (no) organiske forbindelser
BRPI0718478A2 (pt) Compostos orgânicos
DK2091945T3 (da) Nye inhibitorer af glutaminylcyclase
EA201100037A1 (ru) Органические соединения
DK2240490T3 (da) Organiske forbindelser
ATE434618T1 (de) Spirozyklische verbindungen als hdac-hemmer
BRPI0817434A2 (pt) Composto orgânicos
ATE510832T1 (de) Heterocyclische verbindungen als c-fms- kinasehemmer
ECSP11010770A (es) Compuesto heterocíclico y su uso
EA200900945A1 (ru) Новый способ синтеза агомелатина
BRPI0712902A2 (pt) compostos orgânicos
CY1113916T1 (el) Παραγωγα ετεροαρυλο πυρρολιδινυλο και πιπεριδινυλο κετονης
BRPI0821401A2 (pt) Compostos orgânicos
ATE499367T1 (de) 1,3-dihydroimidazol-2-thionderivate als inhibitoren von dopamin-beta-hydroxylase
CR10409A (es) Spirocyclic nitriles as protease inhibitors
EA200900946A1 (ru) Новый способ синтеза агомелатина

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application